Jane Street’s Terns Pharmaceuticals TERN Stock Holding History

Jane Street’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-135,800	Closed	-$7.16M	–	13113
2026 Q1	$7.16M	Buy	135,800 +52,800	+64%	+$2.17M	﹤0.01%	2983
2025 Q4	$3.35M	Buy	83,000 +68,700	+480%	+$1.59M	﹤0.01%	3867
2025 Q3	$107K	Buy	+14,300	New	+$91.3K	﹤0.01%	10107
2024 Q4	–	Sell	-31,500	Closed	-$263K	–	10569
2024 Q3	$263K	Buy	+31,500	New	+$259K	﹤0.01%	8244

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's TERN Position: Q2 2026 in Review

Jane Street sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 7,231 shares — an estimated $381K sold.

Jane Street first reported a position in TERN in Q2 2021 and held it in 13 quarters. The position peaked at $3.59M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Jane Street reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jane Street sold 7,231 Terns Pharmaceuticals shares in Q2 2026, an estimated $381K.
Jane Street first reported a position in Terns Pharmaceuticals in Q2 2021 and held it in 13 quarters.
Jane Street's Terns Pharmaceuticals position peaked at $3.59M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.